157 related articles for article (PubMed ID: 33844690)
1. Establishment of reference intervals for Platelet Function Analyzer -100 closure time in Algerian adults.
Belkacemi M; Merad Y; Merbouh MA
PLoS One; 2021; 16(4):e0249402. PubMed ID: 33844690
[TBL] [Abstract][Full Text] [Related]
2. [Reconfirmation of preanalytical variables and establishment of reference intervals of platelet function analyzer-100 closure times in Korean adults].
Cho YU; Chi HS; Jang S; Park CJ
Korean J Lab Med; 2007 Oct; 27(5):318-23. PubMed ID: 18094595
[TBL] [Abstract][Full Text] [Related]
3. PFA-100 system: a new method for assessment of platelet dysfunction.
Mammen EF; Comp PC; Gosselin R; Greenberg C; Hoots WK; Kessler CM; Larkin EC; Liles D; Nugent DJ
Semin Thromb Hemost; 1998; 24(2):195-202. PubMed ID: 9579642
[TBL] [Abstract][Full Text] [Related]
4. Use of a novel platelet function analyzer (PFA-100) with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand's disease and other disorders.
Favaloro EJ; Facey D; Henniker A
Am J Hematol; 1999 Nov; 62(3):165-74. PubMed ID: 10539883
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of the INNOVANCE PFA P2Y test cartridge for the detection of patients with congenital defects of the platelet P2Y₁₂ receptor for adenosine diphosphate.
Scavone M; Germanovich K; Femia EA; Cattaneo M
Thromb Res; 2014 Feb; 133(2):254-6. PubMed ID: 24331208
[TBL] [Abstract][Full Text] [Related]
6. External quality assessment/proficiency testing and internal quality control for the PFA-100 and PFA-200: an update.
Favaloro EJ; Bonar R
Semin Thromb Hemost; 2014 Mar; 40(2):239-53. PubMed ID: 24497116
[TBL] [Abstract][Full Text] [Related]
7. Variables that Influence Platelet Function Analyzer-100™ Closure Times in Healthy Algerian Adults.
Belkacemi M; Merad Y
Int J Appl Basic Med Res; 2021; 11(3):154-159. PubMed ID: 34458117
[TBL] [Abstract][Full Text] [Related]
8. Variables that affect platelet function analyzer-100 (PFA-100) closure times and establishment of reference intervals in Korean adults.
Cho YU; Jang S; Park CJ; Chi HS
Ann Clin Lab Sci; 2008; 38(3):247-53. PubMed ID: 18715853
[TBL] [Abstract][Full Text] [Related]
9. Use of the PFA-100 in the assessment of primary, platelet-related hemostasis in a pediatric setting.
Rand ML; Carcao MD; Blanchette VS
Semin Thromb Hemost; 1998; 24(6):523-9. PubMed ID: 10066147
[TBL] [Abstract][Full Text] [Related]
10. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
[TBL] [Abstract][Full Text] [Related]
11. Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice.
Posan E; McBane RD; Grill DE; Motsko CL; Nichols WL
Thromb Haemost; 2003 Sep; 90(3):483-90. PubMed ID: 12958618
[TBL] [Abstract][Full Text] [Related]
12. The Platelet Function Analyzer (PFA-100): a novel in-vitro system for evaluation of primary haemostasis in children.
Carcao MD; Blanchette VS; Dean JA; He L; Kern MA; Stain AM; Sparling CR; Stephens D; Ryan G; Freedman J; Rand ML
Br J Haematol; 1998 Apr; 101(1):70-3. PubMed ID: 9576184
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of platelet aggregation using a point-of-care instrument in retired racing Greyhounds.
Couto CG; Lara A; Iazbik MC; Brooks MB
J Vet Intern Med; 2006; 20(2):365-70. PubMed ID: 16594595
[TBL] [Abstract][Full Text] [Related]
14. PFA-100 System: A New Method for Assessment of Platelet Dysfunction.
Mammen EF; Comp PC; Gosselin R; Greenberg C; Hoots WK; Kessler CM; Larkin EC; Liles D; Nugent DJ
Semin Thromb Hemost; 2024 Jun; 50(4):664-671. PubMed ID: 38092024
[TBL] [Abstract][Full Text] [Related]
15. Standardization of the PFA-100(R) platelet function test in 105 mmol/l buffered citrate: effect of gender, smoking, and oral contraceptives.
Böck M; De Haan J; Beck KH; Gutensohn K; Hertfelder HJ; Karger R; Heim MU; Beeser H; Weber D; Kretschmer V
Br J Haematol; 1999 Sep; 106(4):898-904. PubMed ID: 10519990
[TBL] [Abstract][Full Text] [Related]
16. The use of regression analysis in determining reference intervals for low hematocrit and thrombocyte count in multiple electrode aggregometry and platelet function analyzer 100 testing of platelet function.
Kuiper GJAJM; Houben R; Wetzels RJH; Verhezen PWM; Oerle RV; Ten Cate H; Henskens YMC; Lancé MD
Platelets; 2017 Nov; 28(7):668-675. PubMed ID: 28067094
[TBL] [Abstract][Full Text] [Related]
17. The platelet function analyzer (PFA-100) may not be suitable for monitoring the therapeutic efficiency of von willebrand concentrate in type III von willebrand disease.
Meskal A; Vertessen F; Van der Planken M; Berneman ZN
Ann Hematol; 1999 Sep; 78(9):426-30. PubMed ID: 10525831
[TBL] [Abstract][Full Text] [Related]
18. Hemostatic function in healthy pregnant and preeclamptic women: an assessment using the platelet function analyzer (PFA-100) and thromboelastograph.
Davies JR; Fernando R; Hallworth SP
Anesth Analg; 2007 Feb; 104(2):416-20. PubMed ID: 17242101
[TBL] [Abstract][Full Text] [Related]
19. Assessment of primary hemostasis by PFA-100 analysis in a tertiary care center.
Ortel TL; James AH; Thames EH; Moore KD; Greenberg CS
Thromb Haemost; 2000 Jul; 84(1):93-7. PubMed ID: 10928477
[TBL] [Abstract][Full Text] [Related]
20. Towards 50 years of platelet function analyser (PFA) testing.
Favaloro EJ; Pasalic L; Lippi G
Clin Chem Lab Med; 2023 Apr; 61(5):851-860. PubMed ID: 35859143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
